Desipramine-d₄ (hydrochloride)

Desipramine-d₄ is intended for use as an internal standard for the quantification of desipramine by GC- or LC-MS. Desipramine is a tricyclic antidepressant and an active metabolite of imipramine (Item No. 15890).¹ It inhibits the serotonin (5-HT) and norepinephrine transporters (K_is = 163 and 3.5 nM for human SERT and NET, respectively) and is an antagonist of the 5-HT receptor subtype 5-HT_2A and the α₁-adrenergic receptor (α₁-AR), as well as histamine H₁ and muscarinic acetylcholine receptors (mAChRs; K_is = 115, 23, 31, and 37 nM, respectively). Desipramine is selective for the 5-HT_2A receptor over the 5-HT_1A receptor (K_i = 2,272 nM) and for α₁-AR over α₂-AR (K_i = 1,379 nM). It also selectively inhibits G protein-activated inward rectifier potassium channel (GIRK), also known as K_ir3, currents in Xenopus oocytes expressing human GIRK1 and GIRK2 or human GIRK1 and GIRK4 (IC₅₀s = 36.4 and 53.9 µM, respectively) over K_ir1.1 or K_ir2.1 currents in Xenopus oocytes expressing the human channels (IC₅₀s = >100 µM for both).² Desipramine (3.2 mg/kg) decreases immobility time in the forced swim test in mice.³ It also decreases flinching, as well as paw biting and licking, in the second phase of the formalin test in rats.⁴ Formulations containing desipramine have been used in the treatment of depression.

WARNING This product is not for human or veterinary use.

1. Owens, M.J., Neal, W., Plott, S.J., et al. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. 283(3), 1305-1322 (1997).

2. Kobayashi, T., Washiyama, K., and Ikeda, K. Inhibition of G protein-activated inwardly rectifying K⁺ channels by various antidepressant drugs. Neuropsychopharmacology 29(10), 1841-1851 (2004).

3. Koek, W., Sandoval, T.L., and Daws, L.C. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice. Behav. Pharmacol. 29(5), 453-456 (2018).

4. Swaynok, J., Esser, M.J., and Reid, A.R. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82(2), 149-158 (1999).